6 insiders reported 8 Form 4 transactions for Actinium Pharmaceuticals, Inc. (ATNM) over the past 18 months (most recent 2026-09-04). Recent activity: Steinhart Richard I (Director) Buy 62,800 shares, Almenoff June Sherie (Director) Buy 18,000 shares, SETH SANDESH (Chief Executive Officer) Buy 753,600 shares, Nicholson, C. David (Director) Buy 62,800 shares, Shetty Ajit (Director) Buy 61,600 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-04 | Steinhart Richard I | Director | Buy | 62,800 | $0 |
| 2026-09-04 | Almenoff June Sherie | Director | Buy | 18,000 | $0 |
| 2026-09-04 | SETH SANDESH | Chief Executive Officer | Buy | 753,600 | $0 |
| 2026-09-04 | Nicholson, C. David | Director | Buy | 62,800 | $0 |
| 2026-09-04 | Shetty Ajit | Director | Buy | 61,600 | $0 |
| 2026-09-04 | Chell Jeffrey W. | Director | Buy | 61,600 | $0 |
| 2026-09-04 | SETH SANDESH | Chief Executive Officer | Buy | 1.0M | $0 |
| 2025-08-20 | SETH SANDESH | Chief Executive Officer | Sell | 120,900 | $206,739 |
来源：SEC Form 4 申报文件 · 截至 2026-09-04